Eagan, MN, USA - ABM Respiratory Care, a medical device company focused on developing novel integrated airway clearance and ventilation solutions, is proud to announce the market introduction of BiWaze® Airway Clearance System. BiWaze is an innovative cough therapy system designed to remove secretions in the upper airways instead of invasive suctioning.
BiWaze is the respiratory therapy system that combines multiple therapies of assisted cough and lung expansion along with high frequency oscillation, BiWaze breaks up and then removes mucus from the lungs by applying positive air pressure (inhale) to the airway and then rapidly shifting to negative air pressure (exhale). After exhale, the pause phase allows the user to rest before the next assisted cough cycle. BiWaze can provide positive pressure flow during the pause phase so the person’s airways are stinted open after the exhale instead of being forcefully reopened with the next inhale.
The BiWaze Airway Clearance System was inspired by people who need airway clearance treatments tailored to their changing respiratory needs. The dual airpath control separates the inhale and exhale air flow to help ensure the inhaled air is not contaminated with mucus from the exhaled air. The low profile design and simplified touch screen navigation make BiWaze easy to use. The system provides a non-invasive solution to enhance airway clearance is essential to avoid retained mucus that causes infection, inflammation, and respiratory failure. Each therapy cycle can be personalized to provide the most effective therapy for a person’s respiratory condition.
BiWaze is the smallest and lightest (9 lbs) assisted cough device on the market and comes with a built-in battery which can deliver up to 2 hours of continous therapy on one battery charge. The low profile design and touch screen navigation offers a user friendly experience. BiWaze Cough provides a non-invasive solution to clear secretions from the upper airways as compared to invasive suctioning. It also provides high frequency oscillations to break up thick secretions and help remove them from the lungs. Each therapy cycle can be personalized to provide the most effective therapy for a person's respiratory condition. In addition to these features, the device leverages an unique BiWaze platform engine that has two separate paths and blowers for managing inhale and exhale breaths which is unlike any other cough device on the market. The unique BiWaze engine also provides an improved control of the airflow through the device and efficient oscillations in all phases of therapy.
BiWaze is designed to provide cleaner care, easier implementation and, is a smarter solution. To put it simply, BiWaze is a breath of fresh care.
To learn more about BiWaze visit, https://abmrc.com/biwaze/
About ABM Respiratory Care
Founded in 2017, ABM Respiratory Care is dedicated to advancing the healthcare industry by developing intelligent, clinically differentiated and innovative respiratory care solutions to help people breathe better inside and outside the hospital. Our connected platform is designed to improve the standard of care for people with compromised respiratory systems, in any care setting around the world. For more information visit, www.abmrc.com.
Investor and Media Contact:
Leah Noaeill
VP of Marketing and Clinical Affairs, ABM Respiratory Care
Leah.Noaeill@ABMRC.com
1.877.226.7201
SOURCE ABM Respiratory Care